We would like to use cookies to ensure we give you the best experience on our website, privacy policy. If you consent to us using cookies, please click on the tick.

FICPI, The International Federation of Intellectual Property Attorneys

Please mention that you found this IP professional through the FICPI website.

Dott. Roberto Pistolesi

Dott. Roberto
Dragotti & Associati S.R.L.

Via Nino Bixio, 7



Tel: +39-02-2901 4418

Fax: +39-02-2900 3139



Degree in Bio-Organic Chemistry (Università degli Studi di Milano)

CEIPI diploma on patent litigations in Europe

Bar admissions

Since June 1998: Italian patent agent

Since September 1999: Italian trademark agent

Since March 2000: European patent attorney

Since June 2000:
Community trademark attorney

Professional Experience

Partner and CEO of Dragotti & Associati.

Roberto has an extensive experience both in prosecution and opposition procedures before the EPO, where he has been involved in more than 50 cases before the Opposition Divisions or the Boards of Appeal. He also has a wide expertise in multi-national patent litigations, having been involved in several litigations both in Italy and abroad (mainly USA, UK, Germany and France). In particular, he has been involved in patent litigations concerning the following active principles: alendronic acid, atorvastatin, cefaclor, citalopram, docetaxel, enoxaparin,esomeprazole, phosphatidylserine, gabapentin, irbesartan + HCT, latanoprost, olanzapine, omega-3, omeprazole, montelukast, quetiapine, ramipril, repaglinide, rupatadine, salmeterol + fluticasone, and terbinafine. He frequently advises clients on patent strategies and provides infringement and validity opinions.

Roberto has been a technical expert of the Court of Milan since 2002 and of the Court of Venice since 2015, where he assists Judges in patent infringement and/or validity cases.

He was also adjunct Professor at the “Universita’ degli Studi” of Milan from 2011 to 2015, where he taught chemical patent practice to the students of Chemical Science, Industrial Chemistry and Biotechnology.

He has been the Secretary General of FICPI since April 2015. He was the chairman of FICPI’s study and work commission dealing with inventions in the pharma and biotech area from April 2012 to April 2015.

He frequently lectures on intellectual property both in Italy and abroad.
He has published several articles on “Il Sole-24 Ore”, “Pharmachem” and “Il Diritto Industriale”; he is co-author of the Italian and European sections of “Biotechnology and Pharmaceutical Patents – Law and Practice”, Wolters Kluwer, 2008 and 2009 editions.

Country of practice


Country/Region of membership


Associated CET Commissions

CET 5 Biotechnology and Pharmaceuticals

Cookies are required to display this piece of content, please review our cookie consent request (below).